Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Jun 12;189(23):E792-E793.
doi: 10.1503/cmaj.170440.

Drug prices: How do we get to a better place?

Joel Lexchin  1
Affiliations
Comment

Drug prices: How do we get to a better place?

Joel Lexchin. CMAJ. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: In 2015/16, Joel Lexchin received payment from two nonprofit organizations as a consultant on one project that dealt with indication-based prescribing, and a second on which drugs should be distributed free of charge by general practitioners. In 2015, he received payment from a for-profit organization for participation on a panel that discussed expanding drug insurance in Canada. He is on the Foundation Board of Health Action International.

Comment on

Similar articles

See all similar articles

References

    1. Grant K. Rare public hearing highlights concerns over explosion of high-priced specialty drugs in Canada. Globe and Mail [Toronto]. 2017. January 15 Available: www.theglobeandmail.com/news/national/rare-public-hearing-highlights-con... (accessed 2017 Jan. 20).
    1. Morgan S, Leopold C, Wagner A. Drivers of expenditure on primary care prescription drugs in 10 high-income countries with universal health coverage. CMAJ 2017;189:E794–9. - PMC - PubMed
    1. Morgan SG, Lee A. Cost-related non-adherence to prescribed medicines among older adults: a cross-sectional analysis of a survey in 11 developed countries. BMJ Open 2017;7:e014287. - PMC - PubMed
    1. Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 2001;285:421–9. - PubMed
    1. Canadian pharmaceutical industry review 2015. Montréal: imshealth | brogan; 2016. Available: http://imsbrogancapabilities.com/YIR_2015_FINAL (accessed 2016 Oct. 10).